What's new with survival prediction models in acute respiratory failure patients requiring extracorporeal membrane oxygenation

摘要

Introduction: Recent promising data from the 2009 influenza pandemic [1], a positive-although controversial-randomized control trial [2] and major technological advances [3] have contributed to renewed interest in ECMO as a rescue therapy for severe acute respiratory distress syndrome (ARDS). Identifying the specific population who could benefit most from this therapy is crucial. Survival prediction models have recently been developed to help clinicians achieve this goal.